Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
yfGYp1LKhnyQ76LK
Listen
